Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 9 of 9 citing Hassner: Biologic response modifiers in primary immunodeficiency disorders. (0.10 sec) 

Interferon-gamma and host antimicrobial defense: current and future clinical applications


HW Murray - The American journal of medicine, 1994 - Elsevier
In the 1980s, substantive experimental data and emerging clinical results
suggested that interferon-gamma (IFN-γ), a T-cell-derived lymphokine with broad
macrophage-activating effects, had considerable potential in the treatment ...
Cited by 103 - Related articles - BL Direct - All 4 versions

Defects in host defense mechanisms


JWM Van Der Meer, BJ Kullberg - Clinical Approach to Infection in the Compromised …, 1994 - Springer
Under normal conditions, large areas of the human body surface are colonized
with microorganisms. The skin and the mucous membranes of the oropharynx,
nasopharynx, intestinal tract, and parts of the genital tract each have ...
Cited by 38 - Related articles - All 3 versions

Low-cost anti-HIV compounds: potential application for AIDS therapy in developing …


AS Bourinbaiar, V Jirathitikal - Current pharmaceutical design, 2003 - ingentaconnect.com
Abstract: A considerable progress has been made in recent years in the field of
drug development against HIV. However, the current cost of AIDS drugs is the
main obstacle that prevents their use in developing countries, where 95% of ...
Cited by 24 - Related articles - BL Direct - All 6 versions

Does immune serum globulin confer protection against skin diseases?


D Mimouni, M Gdalevich, FB Mimouni, I Grotto … - International journal of dermatology, 2000 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 4 - Related articles - BL Direct - All 4 versions

Successful treatment with cimetidine and zinc sulphate in chronic mucocutaneous …


B Polizzi, L Origgi, G Zuccaro, P Matti, R … - The American journal of the medical sciences, 1996 - journals.lww.com
The authors evaluated the clinical efficacy of a treatment with cimetidine and
zinc sulphate in a patient with chronic mucocutaneous candidiasis. Cimetidine
was given at a dose of 400 mg three times daily; zinc sulphate at a dose of ...
Cited by 4 - Related articles - BL Direct - All 3 versions

[CITATION] Humoral Immunity in the Lung: Expression and Therapeutic Manipulation


W MERRILL - Respiratory Infections: A Scientific Basis for …, 1994 - Saunders
Related articles

[CITATION] 3 Disorders of the lmmune System


RS Shames, JL Kishiyama - Pathophysiology of Disease: An Introduction to …, 1999 - McGraw-Hill/Appleton & Lange
Related articles - All 2 versions

24 Immune System Modulators


PD Hall, G Virella - Medical Immunology, 2007 - books.google.com
24 Immune System Modulators Philip D. Hall Department of Pharmacy and Clinical
Sciences, South Carolina College of Pharmacy, Medical University of South
Carolina, Charleston, South Carolina, USA Gabriel Virella Department of ...
Related articles - All 2 versions

Immune System Modulators

- pmc.ps [PDF] 
PD Hall, JM Goust, G Virella - Medical Immunology - books.google.com
24 Immune System Modulators Philip D. Hall, Iean-Michel Goust, and Gabriel
Virella I. INTRODUCTION A. Immune System Modulators These are agents,
principally drugs, that adjust the activity of a patient's immune response, ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google